PharmSci PhD grad’s research demonstrates how BRCA1 deficiency and alcohol exposure increase risk of DNA damage
Newly published research from U of T’s Leslie Dan Faculty of Pharmacy has uncovered mechanisms that help to explain how the breast cancer 1 susceptibility protein (BRCA1), best known for its role in suppression of breast cancer, helps to prevent developmental disorders and how alcohol exposure may increase the risk of these disorders. Danielle Drake, a recent Pharmaceutical Sciences PhD graduate (2T1 PhD) supervised by Professor Peter Wells, led the research published in Redox Biology in December.
“Someone with a BRCA1 deficiency due to their genetics or environmental factors might be at a greater risk of fetal alcohol spectrum disorders following alcohol exposure during gestation,” says Drake. “By knowing a contributing mechanism for how this deficiency leads to DNA damage, it may be possible to develop therapeutics that target the mechanism and lower the risk of adverse developmental outcomes.”
Wells’ lab focuses on reactive oxygen species (ROS), which are activated forms of oxygen that can damage biological molecules such as proteins, lipids and DNA, consequently leading to cancer, neurodevelopmental disorders or other conditions. Recent work in his lab has examined the effect of alcohol on ROS-mediated DNA damage formation and fetal development.
Throughout Drake’s PhD research, she studied how a deficiency in the BRCA1 DNA repair protein increases ROS formation and ROS-mediated DNA damage in the fetus, as well as how a single fetal alcohol exposure affects DNA repair and developmental gene expression, protein degradation, BRCA1 protein levels, and even and ROS-mediated changes in behaviour. Using a preclinical model, she found that the BRCA1 protein has an important role in suppressing the activity of an enzyme that produces ROS; when the model had low levels of BRCA1 protein, the enzyme produced greater amounts of damaging ROS.
Importantly, when she exposed BRCA1-deficient models to a single dose of alcohol equivalent to a human consuming four to six drinks, BRCA1 levels decreased even further. BRCA1-deficient mice who were exposed to a single dose of alcohol during the fetal period of development exhibited behaviour that differed from animals with normal levels of BRCA1 following a fetal alcohol exposure, suggestive of a neurodevelopmental disorder.
These results give a better understanding of how a BRCA1 deficiency may enhance the risk of fetal alcohol spectrum disorders following a single alcohol exposure in the fetal period of development.
Strong mentorship helped advance network and problem-solving skills
Drake completed her research and defended her thesis in March 2021. In June, she began working as a toxicology associate at a consulting company in the pharmaceutical and biotechnology sector where she uses some of the practical skills she gained during her PhD to review preclinical studies and write reports for regulatory filings.
“My coursework, including the collaborative specialization in biomedical toxicology, a teaching assistant position for the pharmacy introductory toxicology course, and constituents of my research are directly applicable to what I do now,” she says. “Seeing the assays and principles I learned about being commonly used in the real world have affirmed how important this information is.”
Drake found that the Leslie Dan Faculty of Pharmacy offered many opportunities for graduate students to learn, network and form collaborations. She participated in student groups including the Pharmaceutical Sciences Graduate Student Association and the American Association of Pharmaceutical Scientists U of T chapter, both of which were helpful to meet other students, learn about new experimental approaches and form research collaborations.
She also says that Professor Peter Wells’ mentorship helped her gain skills and confidence that have helped in her new career. She had opportunities to present and build her professional network at conferences, and always felt encouraged and supported to take initiative with her project and push it further than originally planned.
“Professor Wells gave me a lot of flexibility and support to be involved in managing different laboratory components and learning various skills that I wouldn’t necessarily have acquired if I was reliant on my supervisor all for all experimental resources,” she says.
“Professor Wells gave me a lot of flexibility and support to be involved in managing different laboratory components and learning various skills that I wouldn’t necessarily have acquired if I was reliant on my supervisor all for all experimental resources,” she says. “He encouraged me to find tools and strategies to solve problems in the lab, and this is beneficial to carrying out tasks in my career now.”
Wells, who has supervised and mentored many students over his career, says that mentoring is one of the most important and satisfying parts of his job.
“Every student has different abilities and interests, and the goal is to help each one develop to their own fullest potential, expanding the breadth and depth of their research and enhancing the quality of their publications and their career success,” says Wells. “The accomplishments of students like Danielle are a great source of pride to the supervisor and contribute to a form of intellectual immortality.”
Learn how scientists at the Centre for Pharmaceutical Oncology are helping researchers at Princess Margaret Cancer Research Centre move a 'swiss-army-knife' nanotheranostic to first-in-human clinical trials.Read More
Lack of knowledge about the placenta is one of the major gaps in studying the health of women and pregnant people. The Piquette-Miller lab is helping to address this by studying how the placenta functions, examining transport proteins that regulate how nutrients, drugs and other molecules cross the placenta to the fetus.Read More
The Ontario government has approved regulatory amendments to enable pharmacists, students, and interns to assess and prescribe for 12 minor ailments.Read More